Navigation Links
Optimer Pharmaceuticals' Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
Date:2/27/2013

the Board that management changes were appropriate following their review of prior compliance, record keeping and conflict-of-interest issues observed during the review, including issues arising from the conduct of Optimer personnel who were the subject of the changes in management and leadership announced in April 2012.  The previously disclosed investigations of these issues by the relevant U.S. authorities are ongoing and the Company continues to cooperate with those authorities.

Dr. McKinnell stated, "While the Board is conducting a comprehensive review of strategic alternatives to maximize shareholder value, I look forward to working with the management team to continue to increase the utilization of DIFICID®."

As scheduled, the Company will report its fourth quarter and year-end 2012 results on February 28th. The Company will report gross product sales of $21.3 million for the fourth quarter of 2012 and of $74.4 million for the year ended December 31, 2012, as announced in January.  The Company will report net income of $0.02 per share, on a basic and diluted basis, for the fourth quarter of 2012 and net loss of $0.79 per share, on both a basic and diluted basis, for the year ended December 31, 2012.

The Board announced that in conjunction with the review of strategic alternatives, the Company has adopted a Rights Plan, expiring on February 15, 2014. The Rights Plan is designed to protect shareholder rights while the strategic review is being conducted. In adopting the Rights Plan, the Board does not presently intend to extend the plan beyond February 15, 2014 without seeking the approval of the Company's shareholders. Additional information regarding the terms and conditions of the Plan are being filed on a Current Report on Form 8-K.

Brief Biography of Dr. McKinnell
Dr. McKinnell was appointed as Chairman of the Board of Optimer in April 2012 and has served as a director since January 2011. From 1971
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
2. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
3. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
4. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
5. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
6. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
7. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
8. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
9. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
10. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
11. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)... REDWOOD CITY, Calif. , Aug. 27, 2014 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that senior management will be ... and presenting at the Morgan Stanley Global Healthcare Conference. ... FBR Healthcare One on One Conference Date: Wednesday ...
(Date:8/26/2014)... Aug. 26, 2014 BioMed Realty Trust, Inc. ... of a new lease with GlycoMimetics, Inc. (NASDAQ: ... square feet at the Center for Life Science | ...  GlycoMimetics is a clinical-stage biotechnology company focused on the ... on an understanding of the role of carbohydrates in ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland 2BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland 3
... (OTC Bulletin Board: NEPH ), a medical ... applications, infection control, and water purification, today announced that ... appointed as President and Chief Executive Officer.  In addition, ... board of directors of Nephros.  Effective upon Mr. Houghton,s ...
... 2012 QBC Diagnostics, a global manufacturer of ... that the company has been awarded a U.S. ... Scientific Equipment and Services. GSA,s Scientific ... agencies with scientific instruments for a wide variety ...
Cached Medicine Technology:Nephros Appoints John C. Houghton as President and Chief Executive Officer 2Nephros Appoints John C. Houghton as President and Chief Executive Officer 3Nephros Appoints John C. Houghton as President and Chief Executive Officer 4Nephros Appoints John C. Houghton as President and Chief Executive Officer 5QBC Diagnostics Awarded GSA Contract 2
(Date:8/27/2014)... 2014 Sugar Manufacturing in ... fluctuations in global supply and demand, which have contributed ... The industry derives a large share of its revenue ... market dynamics, with supply and prices being determined by ... strong Australian dollar for the majority of the past ...
(Date:8/27/2014)... 27, 2014 SCOTT Sports is ... Utah’s first indoor mountain bike and BMX park. SCOTT ... bikes in both adult and youth sizes for the park’s ... a distribution warehouse in Ogden, Utah, recently moved its U.S. ... “We are proud to be a partner with the Wasatch ...
(Date:8/27/2014)... knowledge is power, and a new UCLA study has shown ... making the best decisions about how to treat their prostate ... educated about their disease have a much more difficult time ... negatively impact the quality of their care and their long-term ... for physicians, who can use the findings to target men ...
(Date:8/27/2014)... who eat over 10 portions a week of tomatoes ... prostate cancer, new research suggests. , With 35,000 new ... deaths, prostate cancer is the second most common cancer ... countries, which some experts believe is linked to a ... dietary and lifestyle recommendations reduces risk of prostate cancer, ...
(Date:8/27/2014)... Bedros Keuilian is the founder of the fastest ... fitness boot camp marketing expert in the industry ... thing he knows very well is how to build a ... the fitness business. , In his new, hour-long webinar ... instructional guide on how fitness boot camp owners and personal ...
Breaking Medicine News(10 mins):Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3
... is to create therapies or simply investigate how organisms ... one of biological science's toughest assignments: keeping their tiny ... have notoriously finicky tastes, and despite a decade of ... the cells will continue dividing indefinitely in culture or ...
... to funding are needed to support the rising numbers ... experts. ,Providing quality health services that ... between Federal and State Governments, and public and private ... their editorial for the Medical Journal of Australia, Ms ...
... study shows that repeated treatments of botulinum toxin type ... in a significant decrease in spasticity, pain frequency ... according to research from a neurologist at Wake Forest ... these outcome measures indicate a better quality of life ...
... is turned on its head yet again, this time on what ... is not cotton or linen , but denim and wool, Swiss ... how people protect their skin. ,Writing in a ... the least effective option. ,The team from the ...
... primary open angle glaucoma (POAG) are not treated medically ... study. ,The study is the first investigation ... data from a nationally representative sample of Medicare patients. ... surgeries among adults aged 65 and older by analyzing ...
... the risk of developing health disorders like cardiovascular disease and ... of developing cancer, a new study says. ,Conducted ... Cancer Council of Victoria in Australia - looked into the ... waist measurement of more than 100 centimetres for men and ...
Cached Medicine News:Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 2Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 3Health News:Pain and Intensity Of Post-stroke Spasticity Decreased by Botox Treatment 2Health News:Denim, Not Cotton, Apt Wear for Summer 2